SCARB1 and atherosclerosis: The impaired molecular machinery we observed—including reduced expression of receptors (Scarb1) and transporters (Abca1, Abcg1)—strongly suggests a functional deficit in the lymphatic RCT pathway in advanced atherosclerosis.